Wellspring Biosciences LLC Profile last edited on: 1/25/19
CAGE: 6T0L5
UEI:
Business Identifier: Medicines for treatment of cancer 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
11119 North Torrey Pines Road Suite 125
La Jolla, CA 92037
La Jolla, CA 92037
| (858) 500-8800 |
| inquiries@wellspringbiosciences.com |
| www.wellspringbiosciences.com |
Location: Single
Congr. District: 52
County: San Diego
Congr. District: 52
County: San Diego
Public Profile
Wellspring is organized around the discovery and development of small molecule drugs that target signal transduction networks for the treatment of cancer and other diseases. Through partnerships with academic and industry experts, the firm is translating chemical and biological insights into novel, highly targeted drugs. The team has a proven track record, having previously played important roles in the discovery and development of clinical-stage compounds for the treatment of cancer and immune-mediated inflammatory disease at pharmaceutical company Intellikine. Since early 2013, firm has had close ties to Janssen Biotech (J&J). Parent company is Araxes Pharma with principals of the firm also having close ties Kura Oncology Inc (KURA.OQ).
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2014 | 1 | NIH | $215,385 | |
| Project Title: Development of ATP-Competitive Inhibitors of KSR for the Treatment of Cancer | ||||
| 2013 | 1 | NIH | $225,016 | |
| Project Title: Direct Inhibition Of Mutant K-Ras For The Treatment Of Cancer | ||||
Key People / Management
Troy Wilson -- President, CEO and Co-Founder
Heidi Henson -- Chief Financial Officer
Yi Liu -- Chief Scientific Officer
Anna Nadolski -- Business Advisor
Annette North -- General Counsel
Matthew Patricelli
Pingda Ren -- Senior Vice President, Chemistry
Kevan Shokat -- Scientific Advisor
Heidi Henson -- Chief Financial Officer
Yi Liu -- Chief Scientific Officer
Anna Nadolski -- Business Advisor
Annette North -- General Counsel
Matthew Patricelli
Pingda Ren -- Senior Vice President, Chemistry
Kevan Shokat -- Scientific Advisor
